Literature DB >> 8421112

Lactoferrin in the gingival crevice as a marker of polymorphonuclear leucocytes in periodontal diseases.

E Adonogianaki1, N A Moughal, D F Kinane.   

Abstract

This study examined lactoferrin (LF) levels in gingival crevicular fluid (GCF) and set out to test the hypothesis that LF could act as a marker of crevicular polymorphonuclear leucocytes (PMN). Therefore, 2 experiments were conducted: (a) to quantify total LF (ng/30 s sample) in GCF; (b) to correlate LF levels (ng/microliters) and PMN numbers (PMNs/microliters) in gingival crevicular washings (GCW). GCF was collected from 71 sites in a total of 22 patients. These sites were classified on the basis of clinical indices of gingivitis (GI) and pocket depth (PD) into three clinical groups: 'healthy', 'gingivitis' and 'periodontitis'. GCWs were obtained from an additional 63 sites in 21 patients. LF in GCF and GCWs was assayed by a sandwich ELISA. Total leucocyte and differential counts were performed on the GCWs. GCF LF (ng/30 s) correlated positively with GI (r = 0.418, p < 0.001), PD (r = 0.415, p < 0.001) and GCF volume (r = 0.624, p < 0.001). Gingivitis (n = 21) and periodontitis sites (n = 24) demonstrated significantly higher (p < 0.05) total GCF LF than healthy (n = 26) sites. In GCWs LF (ng/microliters) showed stronger correlations with clinical indices (GI: r = 0.452, PD: r = 0.513, p < 0.001) than did PMN numbers (PMNs/microliters) (GI: r = 0.279, PD: r = 0.388, p < 0.05). LF correlated strongly with PMNs in GCWs (r = 0.531, p < 0.001) and provides a simple and effective marker of crevicular PMN numbers.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8421112     DOI: 10.1111/j.1600-051x.1993.tb01755.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  7 in total

Review 1.  Lactoferrin: A Roadmap to the Borderland between Caries and Periodontal Disease.

Authors:  D H Fine
Journal:  J Dent Res       Date:  2015-03-17       Impact factor: 6.116

2.  Lactoferrin and oral diseases: current status and perspective in periodontitis.

Authors:  Francesca Berlutti; Andrea Pilloni; Miriam Pietropaoli; Antonella Polimeni; Piera Valenti
Journal:  Ann Stomatol (Roma)       Date:  2012-01-27

3.  Inhibitory effects of lactoferrin on growth and biofilm formation of Porphyromonas gingivalis and Prevotella intermedia.

Authors:  Hiroyuki Wakabayashi; Koji Yamauchi; Tetsuo Kobayashi; Tomoko Yaeshima; Keiji Iwatsuki; Hiromasa Yoshie
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

4.  Application of Lactoferrin and α1-Antitrypsin in Gingival Retention Fluid to Diagnosis of Periodontal Disease.

Authors:  Ryosuke Koshi; Kazuhiko Kotani; Mariko Ohtsu; Naoto Yoshinuma; Naoyuki Sugano
Journal:  Dis Markers       Date:  2018-11-07       Impact factor: 3.434

5.  Lactoferrin in Gingival Crevicular Fluid and Peripheral Blood during Experimental Gingivitis.

Authors:  Burcu Ozdemir; Gonen Ozcan; Burcu Karaduman; Asli Idil Teoman; Eylem Ayhan; Nazmi Ozer; Durdal Us
Journal:  Eur J Dent       Date:  2009-01

6.  Estimation of lactoferrin levels in gingival crevicular fluid before and after periodontal therapy in patients with chronic periodontitis.

Authors:  Anasuya V Kivadasannavar; Pushpa S Pudakalakatti; Sanjeevini A Hattarki; Soumya S Kambali
Journal:  Contemp Clin Dent       Date:  2014-01

Review 7.  Oral antimicrobial peptides: Types and role in the oral cavity.

Authors:  Zohaib Khurshid; Mustafa Naseem; Zeeshan Sheikh; Shariq Najeeb; Sana Shahab; Muhammad Sohail Zafar
Journal:  Saudi Pharm J       Date:  2015-03-06       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.